Do you want to read an article? Please log in or register.
The Ellipta® in asthma and chronic obstructive pulmonary disease: device characteristics and patient acceptability
COPD
Related content
COMMENTED
Asthma
Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here
J Allergy Clin Immunol
Dekhuijzen R, Lavorini F, Usmani OS, van Boven JFM
doi: 10.1016/j.jaip.2017.11.027.
RECOMMENDED
COPDSleep Apnea
Prevalence and Predictors of Obstructive Sleep Apnea in Patients with Chronic Obstructive Pulmonary Disease Undergoing Inpatient Pulmonary Rehabilitation
COPD.
Schreiber A, Cemmi F, Ambrosino N, Ceriana P, Lastoria C, Carlucci A
doi: 10.1080/15412555.
COPDPneumonia
Outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary intervention
Eur J Cardiothorac Surg.
Andell P, Sjögren J, Batra G, Szummer K, Koul S
doi: 10.1093/ejcts/ezx219.
AsthmaCOPD
Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
Lancet Respir Med.
Bafadhel M, Peterson S, De Blas MA, Calverley PM, Rennard SI, Richter K, Fagerås M
doi: 10.1016/
COPD
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet Respir Med.
GBD 2015 Chronic Respiratory Disease Collaborators
doi: 10.1016/S2213-2600
COPD
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study
Lancet Respir Med.
Gedebjerg A, Szépligeti SK, Wackerhausen LH, Horváth-Puhó E, Dahl R, Hansen JG, Sørensen HT, Nørgaard M, Lange P, Thomsen RW2
doi: 10.1016/
RECOMMENDED
COPD
Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease
J Am Coll Cardiol.
Adamson PD, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Dixon IJ, Martinez FJ, Newby DE, Vestbo J, Yates JC, Mills NL
doi: 10.1016/j.jacc.2018.06.051.
RECOMMENDED
COPD
Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: Antibiotic Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Semin Respir Crit Care Med.
Gupta N, Haley R, Gupta A, Sethi S
doi: 10.1055/s-0040-1708837.
COMMENTED
COPD
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS
Ann Am Thorac Soc.
Ghosh S, Anderson WH, Putcha N, Han MK, Curtis JL, Criner GJ, Dransfield MT, Barr RG, Krishnan JA, Lazarus SC, Cooper CB, Paine R 3rd, Peters SP, Hansel NN, Martinez FJ, Drummond MB, Current and former investigators of the SPIROMICS sites and reading centers
doi: 10.1513/AnnalsATS.201804-283OC.